Skip to main content
. 2023 Feb 21;14(2):148. doi: 10.1038/s41419-023-05670-x

Fig. 7. A hypothetical model illustrating the METTL14/miR-17-5p/MFN2 axis induces 5-FU chemoresistance in colorectal cancer.

Fig. 7

Low expression of METTL14 in CRC resulted in decreased m6A modification, which in turn reduced the recognition and binding of pri-miR-17 by YTHDC2, promoted the stability of pri-miR-17 mRNA, and increased the expression of miR-17-5p. Overexpressed miR-17-5p inhibited MFN2, leading to decreased mitochondrial fusion and enhanced mitochondrial fission and mitophagy, which ultimately induced drug resistance.